i
urinary
excretion
neutral
17ketosteroids
pregnanediol
patients
breast
cancer
benign
breast
disease
urinary
levels
neutral
17ketosteroid
fractions
pregnanediol
excreted
women
premenopausal
postmenopausal
determined
subjects
studied
included
premenopausal
groups
breast
cancer
benign
breast
disease
sick
control
well
control
postmenopausal
groups
breast
cancer
sick
control
well
control
levels
androsterone
etiocholanolone
excreted
premenopausal
patients
breast
cancer
significantly
less
levels
excreted
premenopausal
groups
differ
significantly
levels
excreted
postmenopausal
patients
breast
cancer
disproportionately
lower
levels
11desoxy17ketosteroids
11oxy17ketosteroids
excreted
premenopausal
patients
cancer
resulted
significantly
lower
ratios
found
premenopausal
groups
ratios
associated
premenopausal
patients
cancer
differ
significantly
postmenopausal
patients
cancer
lower
levels
androsterone
etiocholanolone
explained
debilitation
